journal article·2025-08-22

Copper-Based Responsive Nanoplatform for Synergistic Chemodynamic and Photodynamic Treatment of Osteosarcoma

Yelei Zhang, Yuchao Zhu, Chao Qin, Dingwei Wu, Zewen Wu, Zizhen Liu, Xiao Jia, Wenge Liu

ACS Applied Nano Materials· Volume 8· Issue 33
Publisher page

Abstract

Osteosarcoma (OS) remains a highly aggressive malignancy in adolescents, characterized by rapid metastasis, poor prognosis, and limited response to conventional treatments such as surgery and chemotherapy, largely due to low specificity, severe side effects, and insufficient control of metastatic lesions. The tumor microenvironment (TME) of OS features high GSH levels and elevated oxidative stress, making it particularly susceptible to redox-based therapies. Strategies that amplify reactive oxygen species (ROS), such as chemodynamic therapy (CDT) and photodynamic therapy (PDT), offer selective tumor destruction and overcome conventional treatment limitations. Herein, we report a copper-based metal–organic framework (MOF) nanoplatform, Cu 2 O@CuHHTP@ZnPc@HA (CCHZH), featuring a hierarchical core–shell architecture and glutathione (GSH)-responsive degradability, and active OS-targeting capability. The nanoparticles exhibited a uniform hollow spherical structure with an average diameter of approximately 200 nm. Leveraging both passive targeting via the enhanced permeability and retention (EPR) effect with active targeting through hyaluronic acid (HA)–CD44 interaction, the nanoparticles accumulate selectively at OS sites, subsequently undergoing GSH-triggered disassembly to release Cu + ions and the photosensitizer ZnPc. The liberated Cu + initiates Fenton-like reactions, generating cytotoxic hydroxyl radicals ( • OH) for CDT, while ZnPc produces singlet oxygen ( 1 O 2 ) under 670 nm laser irradiation for PDT. This dual-modal reactive oxygen species (ROS) production synergistically disrupts cellular redox homeostasis, markedly enhancing oxidative stress. Mechanistically, CCHZH with 670 nm laser irradiation activates mitochondrial apoptosis via the Bax/Bcl-2/Caspase-3 signaling axis and simultaneously induces cuproptosis through suppression of FDX1 and LIAS expression. In vitro, CCHZH reduced cell viability to 10% and induced 80% late apoptosis, as confirmed by flow cytometry. Consistently, in vivo evaluations demonstrated potent therapeutic efficacy and safety in subcutaneous, orthotopic, and lung metastasis osteosarcoma models. Collectively, our study introduces a targeted, redox-responsive nanoplatform with robust CDT/PDT synergy and dual-pathway cell death induction, providing a safe and effective therapeutic approach for OS.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopedics

Fujian Medical University Union Hospital

National & Local Joint Biomedical Engineering Research Centre on Photodynamic Technologies, College of Chemistry

Fuzhou University

Funding

Fujian Provincial Department of Science and Technology · Fujian Provincial Health Technology Project

References (55)

Show source-provided references
1. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
2. 10.1186/s13046-024-03249-810.1186/s13046-024-03249-8 ↗
3. 10.1038/s41571-021-00514-z10.1038/s41571-021-00514-z ↗
4. 10.1002/advs.20200358410.1002/advs.202003584 ↗
5. 10.1021/acsami.1c1470110.1021/acsami.1c14701 ↗
6. 10.1155/2022/504139910.1155/2022/5041399 ↗
7. 10.1016/j.bioactmat.2020.12.01010.1016/j.bioactmat.2020.12.010 ↗
8. 10.1186/s12943-024-02105-910.1186/s12943-024-02105-9 ↗
9. 10.1038/s41467-020-20059-610.1038/s41467-020-20059-6 ↗
10. 10.1021/acsami.3c1073310.1021/acsami.3c10733 ↗
11. 10.1016/j.jcis.2023.04.04910.1016/j.jcis.2023.04.049 ↗
12. 10.1002/adfm.20230775610.1002/adfm.202307756 ↗
13. 10.1039/D3NR00867C10.1039/D3NR00867C ↗
14. 10.3389/fphar.2020.0044410.3389/fphar.2020.00444 ↗
15. 10.1016/j.jcis.2025.01.14910.1016/j.jcis.2025.01.149 ↗
16. 10.1186/s12951-024-02308-810.1186/s12951-024-02308-8 ↗
17. 10.1021/acsnano.3c0501110.1021/acsnano.3c05011 ↗
18. 10.1016/j.bios.2022.11455010.1016/j.bios.2022.114550 ↗
19. 10.1021/acsami.3c1888810.1021/acsami.3c18888 ↗
20. 10.1021/jacs.8b0871410.1021/jacs.8b08714 ↗
21. 10.1002/adhm.20210197110.1002/adhm.202101971 ↗
22. 10.1186/s12951-024-02828-310.1186/s12951-024-02828-3 ↗
23. 10.1016/j.jconrel.2023.07.05610.1016/j.jconrel.2023.07.056 ↗
24. 10.1007/s00604-022-05482-410.1007/s00604-022-05482-4 ↗
25. 10.1002/smll.20230644610.1002/smll.202306446 ↗
26. 10.1002/anie.20201340610.1002/anie.202013406 ↗
27. 10.1139/bcb-2015-009310.1139/bcb-2015-0093 ↗
28. 10.1002/smtd.20240051310.1002/smtd.202400513 ↗
29. 10.1039/C7TB01895A10.1039/C7TB01895A ↗
30. 10.1016/j.drudis.2016.12.00910.1016/j.drudis.2016.12.009 ↗
31. 10.3389/fonc.2022.84334510.3389/fonc.2022.843345 ↗
32. 10.1002/adma.20221226710.1002/adma.202212267 ↗
33. 10.1016/j.biomaterials.2020.12064210.1016/j.biomaterials.2020.120642 ↗
34. 10.1002/advs.20241042710.1002/advs.202410427 ↗
35. 10.1016/j.jphotochem.2008.09.01110.1016/j.jphotochem.2008.09.011 ↗
36. 10.1002/anie.20060389510.1002/anie.200603895 ↗
37. 10.1021/jacs.1c1185610.1021/jacs.1c11856 ↗
38. 10.1021/acsanm.4c0690310.1021/acsanm.4c06903 ↗
39. 10.1016/j.biopha.2019.10915610.1016/j.biopha.2019.109156 ↗
40. 10.1186/s13018-023-03717-510.1186/s13018-023-03717-5 ↗
41. 10.3390/nu1504097210.3390/nu15040972 ↗
42. 10.1016/j.jcis.2022.04.09510.1016/j.jcis.2022.04.095 ↗
43. 10.1007/s10853-024-09340-x10.1007/s10853-024-09340-x ↗
44. 10.1021/acssensors.3c0220010.1021/acssensors.3c02200 ↗
45. 10.1002/smll.20150080210.1002/smll.201500802 ↗
46. 10.1021/acsami.2c1741710.1021/acsami.2c17417 ↗
47. 10.1016/j.cej.2023.14579510.1016/j.cej.2023.145795 ↗
48. 10.1002/advs.20220677910.1002/advs.202206779 ↗
49. 10.1021/acsami.1c1103210.1021/acsami.1c11032 ↗
50. 10.1038/s41418-024-01260-210.1038/s41418-024-01260-2 ↗
51. 10.1038/s41422-022-00653-710.1038/s41422-022-00653-7 ↗
52. 10.1016/j.ijbiomac.2018.09.09810.1016/j.ijbiomac.2018.09.098 ↗
53. 10.1038/bjc.1972.3310.1038/bjc.1972.33 ↗
54. 10.1007/s10495-024-02049-x10.1007/s10495-024-02049-x ↗
55. 10.1016/j.phymed.2023.15488110.1016/j.phymed.2023.154881 ↗